Adjuvant chemotherapy combined with pembrolizumab immunotherapy for primary triple-negative neuroendocrine carcinoma of the breast: a case report and literature review.
Saved in:
| Title: | Adjuvant chemotherapy combined with pembrolizumab immunotherapy for primary triple-negative neuroendocrine carcinoma of the breast: a case report and literature review. |
|---|---|
| Authors: | Shen X; Department of Thyroid and Breast Surgery, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China., Yang J; Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University Health Science Center, Changsha, China., Du Y; Department of Thyroid and Breast Surgery, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China., Fu D; Department of Thyroid and Breast Surgery, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China.; Department of Thyroid and Breast Surgery, Northern Jiangsu People's Hospital affiliated to Yangzhou University, Yangzhou, Jiangsu, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 04; Vol. 17, pp. 1848635. Date of Electronic Publication: 2026 Jun 04 (Print Publication: 2026). |
| Publication Type: | Journal Article; Case Reports; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1848635 |
